Showing results (121-130 of 651) with videos related to
Sort By:
Pageof 66
Neuropsychopharmacology Reports|September 8, 2025
Effect of Lemborexant-Based Sleep Medication Formulary on Benzodiazepine Reduction and Clinical Outcomes: A Single-Center Retrospective StudyShunya Aoki, Katsutoshi Takada, Tatsuru Sugama, et al.Neuropsychopharmacology Reports|September 8, 2025
Impact of Confounding Factors in Human Postmortem Brain Tissues on Gene Expression Profiles: A Comparison of Patients With Schizophrenia, Bipolar Disorder, and Nonpsychiatric ControlsMasataka Hatano, Atsuko Nagaoka, Kazusa Miyahara, et al.Neuropsychopharmacology Reports|February 20, 2024
Effect of intermittent subchronic MK-801 administration on dopamine synthesis capacity and responsiveness in the prefrontal cortexKazuro Shibata, Kosuke Enomoto, Takahiro Tsutsumi, et al.Neuropsychopharmacology Reports|March 1, 2024
Research hotspots and frontiers of alcohol and epilepsy: A bibliometric analysisWenhui Liu, Huan Li, Simei LinNeuropsychopharmacology Reports|March 19, 2024
The effective perospirone augmentation with clonazepam for treatment-resistant burning mouth syndrome: A case reportMotoko Watanabe, Chihiro Takao, Chizuko Maeda, et al.Neuropsychopharmacology Reports|March 12, 2024
Assessment on interoceptive awareness on alcohol use and gambling disorders reveals dissociable interoceptive abilities linked to external and internal dependencies: Practical use of Body Perception Questionnaire Very Short Form (BPQ-VSF) in clinical settingsGiselle London, Hiroko Hida, Ariyuki Kagaya, et al.Neuropsychopharmacology Reports|July 4, 2024
Successful utilization of clozapine for a patient with treatment-resistant schizophrenia after recurrent violent behaviorRikuto Christopher Shinohara, Tomomi Oshima, Takafumi Otsubo, et al.Neuropsychopharmacology Reports|April 11, 2024
Decreased oral function in Japanese inpatients with schizophreniaYuichiro Watanabe, Masataka Otake, Shin Ono, et al.Neuropsychopharmacology Reports|April 11, 2024
Can calcitonin gene-related peptide monoclonal antibodies ameliorate writer's cramp and migraine?Keisuke Suzuki, Shiho Suzuki, Hiroaki Fujita, et al.Neuropsychopharmacology Reports|April 8, 2024
Factor structure and psychometric properties of the Jordanian version of the depression anxiety stress scale (DASS-21)Khaled A Al-Dassean, Odeh S MuradPageof 66